Human Cytomegalovirus (HCMV) is an enveloped ubiquitous ds-DNA virus that has been implicated in several types of malignancies. The current work was conducted in the period extending from (November 2018 to the end of October 2019) and aimed to assess the frequency of glycoprotein N (gN) genotypes of HCMV. A total number of 91serum and plasma specimens were collected to fulfill this purpose from females (71 breast cancer patients, and a control group of 20 females) attending Al-Amal hospital for cancer management and Baghdad teaching hospital. The molecular part of this data was achieved through both PCR and Multiplex PCR for detection of HCMV gN (UL73) entire gene as well as for genotyping. gN was detected in 36/71 (50.7%) of breast cancer patients, while gN was detected in 7/20 (35%) of the control group. Furthermore, HCMV gN was successfully genotyped by multiplex PCR in 32/36 (88.88%) of breast cancer patients that were positive for gN and the distribution of each genotype was 46.87% (15/32) for gN-4a, 34.37% (11/32) for gN-1, 12.50% (4/32) for gN-2, 6.25% and 0.0% for gN-4b/c and gN-3b respectively.
